Por favor, use este identificador para citar o enlazar este ítem:
10.1111/jvp.12825
Twittear
Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Badillo Puerta, Elena | - |
dc.contributor.author | Escudero, Elisa | - |
dc.contributor.author | Hernandis Belenguer, Verónica | - |
dc.contributor.author | Galecio, Juan Sebastián | - |
dc.contributor.author | Marín, Pedro | - |
dc.contributor.other | Facultades, Departamentos, Servicios y Escuelas::Departamentos de la UMU::Farmacología | es |
dc.date.accessioned | 2021-03-24T16:12:35Z | - |
dc.date.available | 2021-03-24T16:12:35Z | - |
dc.date.issued | 2020-01 | - |
dc.identifier.citation | J Vet Pharmacol Ther. 2020 Jan;43(1):50-56. | es |
dc.identifier.uri | http://hdl.handle.net/10201/105587 | - |
dc.description.abstract | The single-dose disposition kinetics of cefonicid were determined in clinically normal lactating goats (n=6) after intravenous (IV), intramuscular (IM) and subcutaneous (SC) administration of a conventional formulation, and after subcutaneous administration of a long-acting formulation (SC-LA). Cefonicid concentrations were determined by high performance liquid chromatography with ultraviolet detection. The concentration-time data were analyzed by non-compartmental pharmacokinetic methods. Steady-state volume of distribution (Vss) and clearance (Cl) of cefonicid after IV administration were 0.14 0.03 L/kg and 0.51 0.07 L/h·kg, respectively. Following IM, SC and SC-LA administration, cefonicid achieved maximum plasma concentrations of 14.46 0.82, 11.98 1.92 and 17.17 2.45 mg/L at 0.26 0.13, 0.42 0.13 and 0.83 0.20 hours, respectively. The absolute bioavailabilities after IM, SC and SC-LA routes were 75.34 11.28 %, 71.03 19.14 % and 102.84 15.155 %, respectively. After cefonicid analysis from milk samples, no concentrations were found above LOQ at any sampling time. From these data, cefonicid administered at 20 mg/kg each 12 hours after SC-LA could be effective to treat bacterial infections in lactating animals not affected by mastitis problems. | es |
dc.format | application/pdf | es |
dc.format.extent | 21 | es |
dc.language | eng | es |
dc.relation | Sin financiación externa a la Universidad | es |
dc.rights | info:eu-repo/semantics/openAccess | es |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Cefonicid; cephalosporins; goats; long-acting formulation; pharmacokinetics. | es |
dc.title | PHARMACOKINETICS OF CEFONICID IN LACTATING GOATS AFTER INTRAVENOUS, INTRAMUSCULAR AND SUBCUTANEOUS ADMINISTRATION, AND AFTER A LONG-ACTING FORMULATION FOR SUBCUTANEOUS ADMINISTRATION | es |
dc.title.alternative | PHARMACOKINETICS OF CEFONICID IN GOATS | es |
dc.type | info:eu-repo/semantics/article | es |
dc.identifier.doi | 10.1111/jvp.12825 | - |
Aparece en las colecciones: | Artículos: Farmacología |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Cefonicid.pdf | Pharmacokinetic cefonicid goats | 629,34 kB | Adobe PDF | Visualizar/Abrir |
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons